APA način citiranja

Diaby, V., Adunlin, G., Ali, A. A., Zeichner, S. B., de Lima Lopes, G., Kohn, C. G., & Montero, A. J. (2016). Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States. Breast Cancer Res Treat.

Čikaški stil citiranja

Diaby, Vakaramoko, Georges Adunlin, Askal A. Ali, Simon B. Zeichner, Gilberto de Lima Lopes, Christine G. Kohn, i Alberto J. Montero. "Cost-effectiveness Analysis of 1st Through 3rd Line Sequential Targeted Therapy in HER2-positive Metastatic Breast Cancer in the United States." Breast Cancer Res Treat 2016.

MLA način citiranja

Diaby, Vakaramoko, et al. "Cost-effectiveness Analysis of 1st Through 3rd Line Sequential Targeted Therapy in HER2-positive Metastatic Breast Cancer in the United States." Breast Cancer Res Treat 2016.

Upozorenje: Ovi citati možda nisu uvijek 100% točni.